The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model

Biomedicine and Pharmacotherapy

Volumn 65, Issue 1, 2011, Pages 77-84

  Numao, Akiko ^a,b   Hosono, Kanako ^a,b   Suzuki, Tatsunori ^a,b   Hayashi, Izumi ^c   Uematsu, Satoshi ^d   Akira, Shizuo ^d   Ogino, Yukiko ^a   Kawauchi, Hirohito ^a   Unno, Nobuya ^a   Majima, Masataka ^a,b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Graduate School of Medicine   (Japan)

^c NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; COX 2; Endometriosis; MPGES 1; Prostaglandin E2

Indexed keywords

CD31 ANTIGEN; PROSTAGLANDIN E SYNTHASE 1; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENDOMETRIUM; ENZYME REGULATION; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMPLANT; IMPLANTATION; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CYCLOOXYGENASE 2; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; INTRAMOLECULAR OXIDOREDUCTASES; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79951681504     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.12.008     Document Type: Article

References (40)

1. Olive D.L., Pritts E.A. Treatment of endometriosis. N Engl J Med 2001, 345:266-275.
2. Eskenazi B., Warner M.L. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997, 24:235-258.
3. Stanford E.J., Koziol J., Feng A. The prevalence of interstitial cystitis, endometriosis, adhesions, and vulvar pain in women with chronic pelvic pain. J Minim Invasive Gynecol 2005, 12:43-49.
4. Fauconnier A., Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update 2005, 11:595-606.
5. Crosignani P., Olive D., Bergqvist A., Luciano A. Advances in the management of endometriosis: an update for clinicians. Hum Reprod Update 2006, 12:179-189.
6. May K., Becker C.M. Endometriosis and angiogenesis. Minerva Ginecol 2008, 60:245-254.
7. Amano H., Hayashi I., Endo H., Kitasato H., Yamashina S., Maruyama T., et al. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med 2003, 197:221-232.
8. Murakami M., Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res 2004, 43:3-35.
9. Chishima F., Hayakawa S., Sugita K., Kinukawa N., Aleemuzzaman S., Nemoto N., et al. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 2002, 48:50-56.
10. FagottiA, Ferrandina G., Fanfani F., Legge F., Lauriola L., Gessi M., et al. Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters. Hum Reprod 2004, 19:393-397.
11. Wu M.H., Wang C.A., Lin C.C., Chen L.C., Chang W.C., Tsai S.J. Distinct regulation of cyclooxygenase-2 by interleukin-1beta in normal and endometriotic stromal cells. J Clin Endocrinol Metab 2005, 90:286-295.
12. Matsuzaki S., Canis M., Darcha C., Dallel R., Okamura K., Mage G. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 2004, 82:1609-1615.
13. Ozawa Y., Murakami T., Tamura M., Terada Y., Yaegashi N., Okamura K. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice. Fertil Steril 2006, 86:1146-1151.
14. Laschke M.W., Elitzsch A., Scheuer C., Vollmar B., Menger M.D. Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril 2007, 87:163-171.
15. Hull M.L., Prentice A., Wang D.Y., Butt R.P., Phillips S.C., Smith S.K., et al. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. Hum Reprod 2005, 20:350-358.
16. Grosser T., Fries S., FitzGerald G.A. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006, 116:4-15.
17. Kamei D., Murakami M., Sasaki Y., Nakatani Y., Majima M., Ishikawa Y., et al. Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis. Biochem J 2010, 425:361-371.
18. Kamei D., Yamakawa K., Takegoshi Y., Mikami-Nakanishi M., Nakatani Y., Oh-Ishi S., et al. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J Biol Chem 2004, 279:33684-33695.
19. Kamata H., Hosono K., Suzuki T., Ogawa Y., Kubo H., Katoh H., et al. mPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis in mice. Biomed Pharmacother 2010, 64:409-416.
20. Becker C.M., Wright R.D., Satchi-Fainaro R., Funakoshi T., Folkman J., Kung A.L., et al. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. Am J Pathol 2006, 168:2074-2084.
21. Hirata T., Osuga Y., Yoshino O., Hirota Y., Harada M., Takemura Y., et al. Development of an experimental model of endometriosis using mice that ubiquitously express green fluorescent protein. Hum Reprod 2005, 20:2092-2096.
22. Williams C.S., Tsujii M., Reese J., Dey S.K., DuBois R.N. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000, 105:1589-1594.
23. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8.
24. Fujita M., Hayashi I., Yamashina S., Itoman M., Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002, 294:441-447.
25. Kurosaka M., Suzuki T., Hosono K., Kamata Y., Fukamizu A., Kitasato H., et al. Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice. Biomed Pharmacother 2009, 63:627-634.
26. Taylor R.N., Yu J., Torres P.B., Schickedanz A.C., Park J.K., Mueller M.D., et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 2009, 16:140-146.
27. Samuelsson B., Morgenstern R., Jakobsson P.J. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 2007, 59:207-224.
28. Han R., Tsui S., Smith T.J. Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression. J Biol Chem 2002, 277:16355-16364.
29. Naraba H., Yokoyama C., Tago N., Murakami M., Kudo I., Fueki M., et al. Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem 2002, 277:28601-28608.
30. Uematsu S., Matsumoto M., Takeda K., Akira S. Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J Immunol 2002, 168:5811-5816.
31. Sciulli M.G., Seta F., Tacconelli S., Capone M.L., Ricciotti E., Pistritto G., et al. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells. Br J Pharmacol 2003, 138:634-641.
32. Koeberle A., Rossi A., Zettl H., Pergola C., Dehm F., Bauer J., et al. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase. J Pharmacol Exp Ther 2010, 332:840-848.
33. Xu D., Rowland S.E., Clark P., Giroux A., Cote B., Guiral S., et al. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation. J Pharmacol Exp Ther 2008, 326:754-763.
34. Mbalaviele G., Pauley A.M., Shaffer A.F., Zweifel B.S., Mathialagan S., Mnich S.J., et al. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor. Biochem Pharmacol 2010, 79:1445-1454.
35. Chishima F., Hayakawa S., Yamamoto T., Sugitani M., Karasaki-Suzuki M., Sugita K., et al. Expression of inducible microsomal prostaglandin E synthase in local lesions of endometriosis patients. Am J Reprod Immunol 2007, 57:218-226.
36. Lousse J.C., Defrere S., Colette S., Van Langendonckt A., Donnez J. Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis. Hum Reprod 2010, 25:734-741.
37. Yoshida S., Amano H., Hayashi I., Kitasato H., Kamata M., et al. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab Invest 2003, 83:1385-1394.
38. Machado D.E., Berardo P.T., Palmero C.Y., Nasciutti L.E. Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases. J Exp Clin Cancer Res 2010, 29:4.
39. UenoT, Suzuki T., Oikawa A., Hosono K., Kosaka Y., Amano H., et al. Recruited bone marrow cells expressing the EP3 prostaglandin E receptor subtype enhance angiogenesis during chronic inflammation. Biomed Pharmacother 2010, 64:93-100.
40. Kamoshita E., Ikeda Y., Fujita M., Amano H., Oikawa A., Suzuki T., et al. Recruitment of a prostaglandin E receptor subtype. EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am J Pathol 2006, 169:1458-1472.